Table 4.4 Reported cases of laboratory-confirmed, chronic hepatitis C virus (HCV) infection, by sex, race/ethnicity, age group, and case criteria — Emerging Infections Program (EIP) Enhanced Viral Hepatitis Surveillance, 2009
|
Category
|
CO No. (%) |
CT No. (%) |
MN No. (%) |
NM No. (%) |
NY State No. (%) |
NY City No. (%) |
San Francisco No. (%) |
Total No. (%) |
|---|---|---|---|---|---|---|---|---|
|
Sex
|
||||||||
|
Female
|
1,146 (33.6) | 1,246 (33.3) | 629 (32.5) | 809 (27.3) | 2,535 (32.4) | 3,889 (35.9) | 689 (30.6) | 10,943 (33.2) |
|
Male
|
2,257 (66.1) | 2,495 (66.7) | 1,262 (65.1) | 2,152 (72.7) | 5,273 (67.4) | 6,901 (63.6) | 1,527 (67.9) | 21,867 (66.5) |
|
Missing/
Unknown* |
13 (0.4) | 0 (0.0) | 46 (2.4) | 1 (0.0) | 13 (0.2) | 56 (0.5) | 34 (1.5) | 163 (0.5) |
|
Race/Ethnicity
|
||||||||
|
American Indian/
Alaska Native |
38 (1.1) | 5 (0.1) | 93 (4.8) | 48 (1.6) | 37 (0.5) | 1 (0.0) | 15 (0.7) | 237 (0.7) |
|
Asian/Pacific
Islander |
19 (0.6) | 36 (1.0) | 34 (1.8) | 6 (0.2) | 78 (1.0) | 118 (1.1) | 94 (4.2) | 385 (1.2) |
|
Black,
non-Hispanic |
191 (5.6) | 412 (11.0) | 278 (14.4) | 9 (0.3) | 1,103 (14.1) | 1,291 (11.9) | 488 (21.7) | 3,772 (11.4) |
|
White,
non-Hispanic |
1,143 (33.5) | 1,510 (40.4) | 863 (44.6) | 290 (9.8) | 3,002 (38.4) | 638 (5.9) | 690 (30.7) | 8,136 (24.7) |
|
Hispanic
|
372 (10.9) | 564 (15.1) | 46 (2.4) | 402 (13.6) | 788 (10.1) | 455 (4.2) | 159 (7.1) | 2,786 (8.4) |
|
Other
|
12 (0.4) | 9 (0.2) | 12 (0.6) | 0 (0.0) | 73 (0.9) | 209 (1.9) | 28 (1.2) | 343 (1.0) |
|
Missing/
Unknown |
1,641 (48.0) | 1,205 (32.2) | 611 (31.5) | 2,207 (74.5) | 2,740 (35.0) | 8,134 (75.0) | 776 (34.5) | 17,314 (52.5) |
|
Age group (yrs)
|
||||||||
|
0-14
|
10 (0.3) | 6 (0.2) | 14 (0.7) | 5 (0.2) | 13 (0.2) | 74 (0.7) | 7 (0.3) | 129 (0.4) |
|
15-24
|
95 (2.8) | 161 (4.3) | 62 (3.2) | 288 (9.7) | 316 (4.0) | 313 (2.9) | 33 (1.5) | 1,268 (3.8) |
|
25-39
|
716 (21.0) | 746 (20.0) | 292 (15.1) | 1,032 (34.8) | 1,262 (16.1) | 1,925 (17.8) | 301 (13.4) | 6,274 (19.0) |
|
40-54
|
1,642 (48.1) | 1,756 (46.9) | 978 (50.0) | 1,146 (38.7) | 3,518 (45.0) | 4,207 (38.8) | 987 (43.9) | 14,234 (43.2) |
|
≥55
|
946 (27.7) | 1,072 (28.7) | 587 (30.3) | 490 (16.5) | 2,702 (34.6) | 4,327 (39.9) | 920 (40.9) | 11,044 (33.5) |
|
Missing*
|
7 (0.2) | 0 (0.0) | 4 (0.2) | 1 (0.0) | 10 (0.1) | 0 (0.0) | 2 (0.1) | 24 (0.1) |
|
Case criteria§
|
||||||||
|
Anti-HCV and
supplemental test |
222 (6.5) | 178 (4.8) | 251 (13.0) | U§ | 883 (11.3) | 1,005 (9.3) | 7 (0.3) | 2,546 (7.7) |
|
RIBA
|
375 (11.0) | 317 (8.5) | 451 (23.3) | U | 1,106 (14.1) | 1,680 (15.5) | 33 (1.5) | 3,962 (12.0) |
|
HCV RNA
|
1,812 (53.0) | 983 (26.3) | 1,366 (70.5) | U | 5,108 (65.3) | 4,592 (42.3) | 1,470 (65.3) | 15,331 (46.5) |
|
Genotype
|
935 (27.4) | 80 (2.1) | 556 (28.7) | U | 839 (10.7) | 2,222 (20.5) | 613 (27.2) | 5,245 (15.9) |
|
Anti-HCV and
s/co ratio |
1,632 (47.8) | 2,797 (74.8) | 693 (35.8) | U | 4,468 (57.1) | 8,440 (77.8) | 1,297 (57.6) | 19,327 (58.6) |
|
Total new
reported cases |
3,416 | 3,741 | 1,937 | 2,962 | 7,821 | 10,846 | 2,250 | 32,973 |
|
Estimated 2009
population |
5,024,748 | 3,518,288 | 5,266,214 | 2,009,671 | 4,265,336 | 8,391,881 | 815,358 | 29,291,486 |
|
Rate¶
|
68.0 | 106.3 | 36.8 | 147.4 | 183.4 | 129.2 | 276.0 | 112.6 |
*”Missing” refers to case reports for which data are absent, whereas “unknown” refers to case reports for which an attempt was made to capture this information, but no valid response was provided.
†More than one laboratory result can accompany each case report.
§U=No data available for reporting.
¶Rate per 100,000 population.